List of Tables
    Table 1. Anti-Ageing Drugs CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Anti-Ageing Drugs Market Trends
    Table 3. Anti-Ageing Drugs Market Drivers
    Table 4. Anti-Ageing Drugs Market Challenges
    Table 5. Anti-Ageing Drugs Market Restraints
    Table 6. Global Anti-Ageing Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Anti-Ageing Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Anti-Ageing Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Anti-Ageing Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Anti-Ageing Drugs Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Anti-Ageing Drugs Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Anti-Ageing Drugs Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Anti-Ageing Drugs Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Anti-Ageing Drugs Sales Share by Manufacturer, 2017-2022
    Table 15. Global Anti-Ageing Drugs Price by Manufacturer (2017-2022) & (USD/Unit)
    Table 16. Global Anti-Ageing Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Anti-Ageing Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Ageing Drugs as of 2021)
    Table 18. Top Players of Anti-Ageing Drugs in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Anti-Ageing Drugs Product Type
    Table 20. Date of International Manufacturers Enter into Anti-Ageing Drugs Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Anti-Ageing Drugs Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Anti-Ageing Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Anti-Ageing Drugs Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Anti-Ageing Drugs Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Anti-Ageing Drugs Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Anti-Ageing Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Anti-Ageing Drugs Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Anti-Ageing Drugs Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Anti-Ageing Drugs Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Anti-Ageing Drugs Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Anti-Ageing Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Anti-Ageing Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Anti-Ageing Drugs Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Anti-Ageing Drugs Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Anti-Ageing Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Anti-Ageing Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Anti-Ageing Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Anti-Ageing Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Anti-Ageing Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Anti-Ageing Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Nu Skin Corporation Information
    Table 43. Nu Skin Description and Business Overview
    Table 44. Nu Skin Anti-Ageing Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 45. Nu Skin Anti-Ageing Drugs Product
    Table 46. Nu Skin Recent Development
    Table 47. BIOTIME Corporation Information
    Table 48. BIOTIME Description and Business Overview
    Table 49. BIOTIME Anti-Ageing Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 50. BIOTIME Product
    Table 51. BIOTIME Recent Development
    Table 52. Elysium Health Corporation Information
    Table 53. Elysium Health Description and Business Overview
    Table 54. Elysium Health Anti-Ageing Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 55. Elysium Health Product
    Table 56. Elysium Health Recent Development
    Table 57. La Roche-Posay Corporation Information
    Table 58. La Roche-Posay Description and Business Overview
    Table 59. La Roche-Posay Anti-Ageing Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 60. La Roche-Posay Product
    Table 61. La Roche-Posay Recent Development
    Table 62. DermaFix Corporation Information
    Table 63. DermaFix Description and Business Overview
    Table 64. DermaFix Anti-Ageing Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 65. DermaFix Product
    Table 66. DermaFix Recent Development
    Table 67. Key Raw Materials Lists
    Table 68. Raw Materials Key Suppliers Lists
    Table 69. Anti-Ageing Drugs Customers List
    Table 70. Anti-Ageing Drugs Distributors List
    Table 71. Research Programs/Design for This Report
    Table 72. Key Data Information from Secondary Sources
    Table 73. Key Data Information from Primary Sources
List of Figures
    Figure 1. Anti-Ageing Drugs Product Picture
    Figure 2. Global Anti-Ageing Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Anti-Ageing Drugs Market Size 2017-2028 (US$ Million)
    Figure 4. Global Anti-Ageing Drugs Sales 2017-2028 (K Units)
    Figure 5. United States Anti-Ageing Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Anti-Ageing Drugs Market Size 2017-2028 (US$ Million)
    Figure 7. United States Anti-Ageing Drugs Sales 2017-2028 (K Units)
    Figure 8. United States Anti-Ageing Drugs Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Anti-Ageing Drugs Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Anti-Ageing Drugs Report Years Considered
    Figure 11. Product Picture of Hormonal Therapy
    Figure 12. Product Picture of Antioxidants
    Figure 13. Product Picture of Enzymes
    Figure 14. Product Picture of Stem Cells
    Figure 15. Product Picture of Others
    Figure 16. Global Anti-Ageing Drugs Market Share by Type in 2022 & 2028
    Figure 17. Global Anti-Ageing Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 18. Global Anti-Ageing Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 19. Global Anti-Ageing Drugs Sales by Type (2017-2028) & (K Units)
    Figure 20. Global Anti-Ageing Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 21. Global Anti-Ageing Drugs Price by Type (2017-2028) & (USD/Unit)
    Figure 22. United States Anti-Ageing Drugs Market Share by Type in 2022 & 2028
    Figure 23. United States Anti-Ageing Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 24. United States Anti-Ageing Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 25. United States Anti-Ageing Drugs Sales by Type (2017-2028) & (K Units)
    Figure 26. United States Anti-Ageing Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 27. United States Anti-Ageing Drugs Price by Type (2017-2028) & (USD/Unit)
    Figure 28. Product Picture of Skin
    Figure 29. Product Picture of Hair
    Figure 30. Product Picture of Others
    Figure 31. Global Anti-Ageing Drugs Market Share by Application in 2022 & 2028
    Figure 32. Global Anti-Ageing Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 33. Global Anti-Ageing Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 34. Global Anti-Ageing Drugs Sales by Application (2017-2028) & (K Units)
    Figure 35. Global Anti-Ageing Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 36. Global Anti-Ageing Drugs Price by Application (2017-2028) & (USD/Unit)
    Figure 37. United States Anti-Ageing Drugs Market Share by Application in 2022 & 2028
    Figure 38. United States Anti-Ageing Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 39. United States Anti-Ageing Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 40. United States Anti-Ageing Drugs Sales by Application (2017-2028) & (K Units)
    Figure 41. United States Anti-Ageing Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 42. United States Anti-Ageing Drugs Price by Application (2017-2028) & (USD/Unit)
    Figure 43. North America Anti-Ageing Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 44. North America Anti-Ageing Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 45. U.S. Anti-Ageing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Canada Anti-Ageing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Europe Anti-Ageing Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 48. Europe Anti-Ageing Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 49. Germany Anti-Ageing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. France Anti-Ageing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. U.K. Anti-Ageing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Italy Anti-Ageing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Russia Anti-Ageing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Asia-Pacific Anti-Ageing Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 55. Asia-Pacific Anti-Ageing Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 56. China Anti-Ageing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Japan Anti-Ageing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. South Korea Anti-Ageing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. India Anti-Ageing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Australia Anti-Ageing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Taiwan Anti-Ageing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Indonesia Anti-Ageing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Thailand Anti-Ageing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Malaysia Anti-Ageing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Philippines Anti-Ageing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Latin America Anti-Ageing Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 67. Latin America Anti-Ageing Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 68. Mexico Anti-Ageing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Brazil Anti-Ageing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Argentina Anti-Ageing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Middle East & Africa Anti-Ageing Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 72. Middle East & Africa Anti-Ageing Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 73. Turkey Anti-Ageing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. Saudi Arabia Anti-Ageing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 75. U.A.E Anti-Ageing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 76. Anti-Ageing Drugs Value Chain
    Figure 77. Anti-Ageing Drugs Production Process
    Figure 78. Channels of Distribution
    Figure 79. Distributors Profiles
    Figure 80. Bottom-up and Top-down Approaches for This Report
    Figure 81. Data Triangulation
    Figure 82. Key Executives Interviewed